Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Rechsteiner

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|June 27, 2022
Targeting ALK in Neuroendocrine Tumors of the LungDilara Akhoundova, Martina Haberecker, Ralph Fritsch, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2019
Histological and molecular characterization of TFEB-rearranged renal cell carcinomasNicolas Wyvekens, Markus Rechsteiner, Christine Fritz, et al.
The Journal of Pathology|September 26, 2012
The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinomaSilvia Casagrande, Melanie Ruf, Markus Rechsteiner, et al.
Head and Neck Pathology|July 17, 2019
New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A MutationNiels J Rupp, Muriel Brada, Alena Skálová, et al.
Virchows Archiv : an International Journal of Pathology|May 23, 2018
New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiationNiels J Rupp, Markus Rechsteiner, Sandra N Freiberger, et al.
Leukemia & Lymphoma|February 22, 2024
Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odysseyKevin D Hofer, Marco M Bühler, Marco Roncador, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2013
KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnosticsMarkus Rechsteiner, Adriana von Teichman, Jan H Rüschoff, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2022
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic NeoplasmsMartina Haberecker, Marco Matteo Bühler, Alicia Pliego Mendieta, et al.
The Journal of Pathology|March 19, 2019
IL-8 and CXCR1 expression is associated with cancer stem cell-like properties of clear cell renal cancerClaudia Corrò, Marc E Healy, Stefanie Engler, et al.
Experimental and Molecular Pathology|February 20, 2017
Detecting circulating tumor DNA in renal cancer: An open challengeClaudia Corrò, Tomas Hejhal, Cédric Poyet, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|June 27, 2022
Targeting ALK in Neuroendocrine Tumors of the LungDilara Akhoundova, Martina Haberecker, Ralph Fritsch, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2019
Histological and molecular characterization of TFEB-rearranged renal cell carcinomasNicolas Wyvekens, Markus Rechsteiner, Christine Fritz, et al.
The Journal of Pathology|September 26, 2012
The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinomaSilvia Casagrande, Melanie Ruf, Markus Rechsteiner, et al.
Head and Neck Pathology|July 17, 2019
New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A MutationNiels J Rupp, Muriel Brada, Alena Skálová, et al.
Virchows Archiv : an International Journal of Pathology|May 23, 2018
New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiationNiels J Rupp, Markus Rechsteiner, Sandra N Freiberger, et al.
Leukemia & Lymphoma|February 22, 2024
Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odysseyKevin D Hofer, Marco M Bühler, Marco Roncador, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2013
KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnosticsMarkus Rechsteiner, Adriana von Teichman, Jan H Rüschoff, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 21, 2022
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic NeoplasmsMartina Haberecker, Marco Matteo Bühler, Alicia Pliego Mendieta, et al.
The Journal of Pathology|March 19, 2019
IL-8 and CXCR1 expression is associated with cancer stem cell-like properties of clear cell renal cancerClaudia Corrò, Marc E Healy, Stefanie Engler, et al.
Experimental and Molecular Pathology|February 20, 2017
Detecting circulating tumor DNA in renal cancer: An open challengeClaudia Corrò, Tomas Hejhal, Cédric Poyet, et al.
Pageof 5